According to Dr. Phil Doren, CEO, “Mr. Charley Bratton will lead an array of activities contributing to the company’s plans for accelerated growth and expansion of service offerings.”
“Abond CRO is excited to have Charley Bratton join our company. He brings years of sales and marketing experience, industry-wide knowledge and an incredible amount of energy to this role. He is well-respected in the industry for providing client service excellence to meet drug and device development needs.
Charley Bratton will add to the leadership team that we have in place to serve our pharmaceutical, biotech and medical device customers. His leadership experience and industry expertise in business development and marketing greatly enhances our organizational capability to provide excellent support in those areas to our customers,” Doren added.
